Annexon Inc (ANNX)
4.88
+0.22
(+4.72%)
USD |
NASDAQ |
May 03, 16:00
5.03
+0.15
(+3.07%)
After-Hours: 20:00
Annexon Enterprise Value: 179.61M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 179.61M |
| May 02, 2024 | 159.80M |
| May 01, 2024 | 167.91M |
| April 30, 2024 | 149.90M |
| April 29, 2024 | 163.40M |
| April 26, 2024 | 163.40M |
| April 25, 2024 | 153.50M |
| April 24, 2024 | 140.90M |
| April 23, 2024 | 140.00M |
| April 22, 2024 | 149.45M |
| April 19, 2024 | 150.80M |
| April 18, 2024 | 140.00M |
| April 17, 2024 | 153.05M |
| April 16, 2024 | 200.76M |
| April 15, 2024 | 257.03M |
| April 12, 2024 | 278.64M |
| April 11, 2024 | 286.74M |
| April 10, 2024 | 295.74M |
| April 09, 2024 | 301.14M |
| April 08, 2024 | 284.94M |
| April 05, 2024 | 297.54M |
| April 04, 2024 | 314.65M |
| April 03, 2024 | 320.95M |
| April 02, 2024 | 318.25M |
| April 01, 2024 | 337.15M |
| Date | Value |
|---|---|
| March 28, 2024 | 385.77M |
| March 27, 2024 | 443.38M |
| March 26, 2024 | 359.66M |
| March 25, 2024 | 338.05M |
| March 22, 2024 | 352.46M |
| March 21, 2024 | 288.54M |
| March 20, 2024 | 260.92M |
| March 19, 2024 | 277.72M |
| March 18, 2024 | 296.28M |
| March 15, 2024 | 331.64M |
| March 14, 2024 | 235.29M |
| March 13, 2024 | 250.31M |
| March 12, 2024 | 146.01M |
| March 11, 2024 | 138.05M |
| March 08, 2024 | 179.60M |
| March 07, 2024 | 174.30M |
| March 06, 2024 | 203.47M |
| March 05, 2024 | 213.19M |
| March 04, 2024 | 259.15M |
| March 01, 2024 | 267.99M |
| February 29, 2024 | 176.80M |
| February 28, 2024 | 170.53M |
| February 27, 2024 | 170.53M |
| February 26, 2024 | 166.61M |
| February 23, 2024 | 151.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-135.12M
Minimum
Mar 30 2022
1.202B
Maximum
Aug 12 2020
239.41M
Average
95.26M
Median
Sep 06 2022
Enterprise Value Benchmarks
| Trxade Health Inc | 15.25M |
| P3 Health Partners Inc | 439.87M |
| Arrowhead Pharmaceuticals Inc | 2.821B |
| Insmed Inc | 4.169B |
| Heron Therapeutics Inc | 485.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.89M |
| Total Expenses (Quarterly) | 30.01M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -36.27% |